TFFP - TFF Pharmaceuticals Inc. (TFFP) CEO Glenn Mattes on Q3 2021 Results - Earnings Call Transcript
TFF Pharmaceuticals, Inc. (TFFP) Q3 2021 Earnings Conference Call November 15, 2021 4:30 PM ET Company Participants Corey Davis - LifeSci Advisors Glenn Mattes - President & Chief Executive Officer Dr. Dale Christensen - Director of Clinical Development Dr. Bill Williams - University of Texas, Austin Kirk Coleman - Chief Financial Officer Chris Cano - Chief Operating Officer Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Sahil Kazmi - B. Riley Securities Michael Okunewitch - Maxim Group Richard Deutsch - National Securities Presentation Operator Greetings, ladies and gentlemen, and thank you for standing by. Welcome to the TFF Pharmaceuticals Third Quarter 2021 Results Conference Call. As a reminder, this conference call is being recorded. A question-and-answer session will follow the formal presentation. [Operator Instructions]. I would now like to introduce Corey Davis of LifeSci Advisors to begin the call. Corey Davis Thank you, operator. Hello, everyone, and welcome to
For further details see:
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q3 2021 Results - Earnings Call Transcript